Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-26 @ 1:40 AM
Study NCT ID:
NCT05058560
Status:
COMPLETED
Last Update Posted:
2025-03-13
First Post:
2021-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab in Addition to BACE in Patients with NSCLC
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-31
First Submit QC Date:
None
Study First Post Date:
2021-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-11
Last Update Post Date:
2025-03-13
Last Update Post Date Type:
ACTUAL